Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO TAT 2021 | Collaborative work to improve cellular therapies by Orgenesis

Vered Caplan • 16 Mar 2021
ESMO TAT 2021
General

Vered Caplan, BSc, Orgenesis, Germantown, MD, discusses a collaboration between Orgenesis and University of California, Davis (UC Davis), which will focus on the production and development of cellular therapies, and a collaboration between Orgenesis and a Korean company. This interview took place during the ESMO TAT 2021 conference.

More from Vered Caplan

4:25
Unmet needs in cellular therapy manufacturing
Vered Caplan • 16 Mar 2021
2:25
The role of Orgenesis in developing cell and gene therapies
Vered Caplan • 16 Mar 2021

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals